内地生物制药公司科济药业(02171.HK)公布招股详细，计划发行9,474.7万股，当中10%为本地发售，90%为国际配售，每股招股价介乎29.6至32.8元，集资最多约31.07亿元。每手500股入场费约16,565.26元，联席保荐人为高盛及瑞银。招股期由下周一(7日)起至下周四(10日)结束，料於6月18日上市。是次招股共引入9名基石投资者，包括礼来亚洲基金、新华人寿、CloudAlpha...
Source Link- 10
- 4
- Favorite
《新股消息》科济药业(02171.HK)下周一起招股 引入礼来等9名基投
AAFN2021-06-04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
10
Report
Login to post
- Kelvin988·2021-06-10HahLikeReport
- 股海摩西·2021-06-06猛1Report
- 王世全·2021-06-06可以融資融券嗎？1Report
- 王世全·2021-06-06醫藥健康是未來投資的取向！LikeReport
Most Discussed
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial